SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0633-1.9%12:39 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LT2011 who wrote (12384)9/9/2013 12:47:09 PM
From: NOREG  Read Replies (1) of 13111
 
Speaking of rotten fish, Friday's WSJ had an article about Pharmas trying to develop vaccines to treat Melanoma and a Doc form M.D Anderson mentioned some with OR's of 21 and 33% and said how great it would be to get 50% - wasn't M.D. part of the phase 2 trials and they should know that PV 10 had an OR of 60% in Australia, according to Provectus, Wonder why PV 10 wasn't mentioned!!!
NOREG
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext